/ Inolex /

Joining David Plimpton, CEO, to champion technology innovation & growth

PHILADELPHIA, PA, September 28, 2022Neil Washburn, Ph.D. has joined the Inolex Executive Team as Interim President. He comes alongside Chief Executive Officer, David Plimpton, to serve on Inolex’s leadership team and further develop the company’s strategic growth.

Inolex is a recognized partner in the industry for its patented technologies that move the beauty and personal care industry forward. Washburn is poised to help the company accelerate its growth in line with the needs of its customers and its current and future innovation platform.

“Innovation is a passion of mine, and I am thrilled to have the opportunity to contribute to the momentum of this company. For me, outcome-oriented innovation means helping strong, talented people thrive, so they can work on solving important challenges. Inolex is already disrupting the ingredient space—my energy will focus on scaling this success by leading near-term initiatives and longer-term strategy as we grow,” said Washburn.


"For me, outcome-oriented innovation means helping strong, talented people thrive, so they can work on solving important challenges." Neil Washburn, Interim President

Washburn joins Inolex after a successful 39-year career at DuPont. He holds a Ph.D. in Analytical Chemistry. Washburn led cross-functional teams across Operations, Research & Development, Marketing, and Business Leadership on a number of transformative projects and high-profile global product initiatives throughout his career. More recently, he has been a strategic advisor to technology and material-oriented start-ups with a focus on sustainability.

“In addition to his technical and business knowledge, Neil exudes our service mindset. His competencies to discern opportunities and make thoughtful decisions is the exact kind of leadership we need as an independent company–complementing our existing Senior Leadership Team as we boldly pursue new customers, new products, and new markets,” said Plimpton.

Related Articles

Inolex Defends Ingredient Innovation with Legal Action

October 2024
Inolex is taking decisive legal action to protect its innovative ingredient technologies and uphold the integrity of its product offerings.

Read More

Inolex granted European patent for safe, sustainable Preservation Technology

February 2024
Building on its safe and sustainable preservation platform with a newly issued European patent EP3075401B1 and the launch of Spectrastat™ CHA.

Read More

Inolex granted patents for Cationic Amino Lipid Technology

February 2024
Bringing the most advanced, sustainable conditioning ingredients on the market to Korea and Brazil

Read More